This item is not yet published. It is available for pre-orders and will ship on 29 June 2025.
1. Introduction to WHO Classification of Tumors of the Central Nervous System, David N. Louis, Pieter Wesseling, and David W. Ellison
2. Gliomas, Glioneuronal, and Neuronal Tumors: Introduction, Michael Weller, Andreas von Deimling, and Daniel Brat
2.1.1. Adult-type diffuse gliomas: Astrocytoma, IDH-Mutant, Martin J. van den Bent, Daniel J. Brat, Frederic Dhermain, and Walter Stummer
2.1.2. Adult-type diffuse gliomas: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, Wolfgang Wick and Guido Reifenberger
2.1.3. Adult-type diffuse gliomas: Glioblastoma, IDH-wildtype, Michael Weller, E. Antonio Chiocca, Sabine Mueller, Jennifer Yu, and Andreas von Deimling
2.2. Pediatric-type diffuse low-grade gliomas, Mariella Filbin, Christine Haberler, Daphne Haas-Kogan, Ian F. Pollack, David A. Reardon, and Sanda Alexandrescu
2.3. Paediatric-type diffuse high-grade gliomas, Michelle Monje, Steven BraunsteiMitchell Berger, and Hannes Vogel
2.4. Circumscribed astrocytic gliomas, Mariella Filbin, Sanda Alexandrescu, Daphne Haas-Kogan, Ian F. Pollack, David A. Reardon, Christine Haberler
2.5. Glioneuronal and neuronal tumours, Riccardo Soffietti, Hugues Duffau, Anita Mahajan, Maria Luisa Garrè, and Jason Huse
2.6. Ependymal Tumours, Mark R. Gilbert, Christina Tsien, Anandani Nellan, Cynthia Campen, Terri S. Armstrong, Mark Souweidane, and Roger McLendon
3. Choroid Plexus Tumours, Didier Frappaz, Nikolaus Andratschke, Roberta Ruda, Manfred Westphal, and Christian Thomas
4. Embryonal Tumours, Samuel Cheshier, François Doz, David W. Ellison, Thomas E. Merchant, and Stefan M. Pfister
5. Pineal tumours, Roger E. Taylor, Felice Giangaspero, Catherine Han, Michael Jenkinson, and Nancy Tarbell
6. Cranial and paraspinal nerve tumours, Joerg Christian Tonn, Warren Mason, Alexander Muacevic, and David Reuss
7. Meningioma, Priscilla K. Brastianos, Roland Goldbrunner, Damien Charles Weber, and Felix Sahm
8. Mesenchymal, non-meningothelial tumours involving the central nervous system, Sith Sathornsumetee, Rakesh Jalali, Manfred Westphal, and Christian Mawrin
9. Melanocytic tumors, Patrick Roth, Loreto Yanez, Ying Mao, and Keith Ligon
10. Haematolymphoid tumours involving the central nervous system: Introduction, Tracy Batchelor
10.1. Lymphomas, Tracy Batchelor, Motoo Nagane, Tejpal Gupta, Lisa Roth, and Maurilio Ponzoni
10.2. Histiocytic Tumors of the Central Nervous System, Oussama Abla and Jennifer Picarsic
11. Germ cell tumors, Manmeet S. Ahluwalia, Matthew D. Hall, Hirokazu Takami, and Torsten Pietsch
12. Tumors of the sellar region, Joachim M. Baehring, Helen Shih, Zhong-Ping Chen, and Sandro Santagata
13. Metastases to the CNS: Introduction, Emilie Le Rhun and Dieta Bransdma
13.1. Metastases to the brain and spinal cord parenchyma, Dieta Brandsma, David Schiff, Susan Short, Marcos Maldaun, and Elisabeth Rushing
13.2. Metastases to the meninges, Emilie Le Rhun, Giuseppe Minniti, Adrienne Boire, and Pieter Wesseling
13.3. Secondary involvement of the central nervous system by hematopoietic malignancies, Tali Siegal, Ofir Wolach, and Osnat Bairey
14. Genetic tumour syndromes involving the CNS: Introduction, Scott R. Plotkin
14.1. Neurofibromatosis 1, Scott R. Plotkin, D. Gareth Evans, Jay Loeffler, Sonia Partap, Shota Tanaka, and Anat Stemmer-Rachamimov
14.2. NF2-related schwannomatosis (formerly known as neurofibromatosis type 2), Scott R. Plotkin, D. Gareth Evans, Jay Loeffler, Sonia Partap, Shota Tanaka, and Anat Stemmer-Rachamimov
14.3. Non-NF2-related schwannomatosis and rhabdoid tumour predisposition syndrome, Scott R. Plotkin, D. Gareth Evans, Jay Loeffler, Sonia Partap, Shota Tanaka, and Anat Stemmer-Rachamimov
14.4. Von Hippel Lindau Disease, Joachim P. Steinbach, Hiroshi Kanno, Othon Iliopoulos, and Karl H. Plate
14.5. Tuberous Sclerosis Complex, Eleonora Aronica, Pradnya Gadgil, Nisha Giridharan, Howard Weiner, Peter B. Crino
14.6. Central and Peripheral Nervous System Tumor Predisposition Syndromes, Ana S. Guerreiro Stucklin, Uri Tabori, and Cynthia Hawkins
Tracy Batchelor, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA,Michael Weller, Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland
Tracy Batchelor is the Chair in the Department of Neurology at Brigham and Women’s Hospital, Co-Leader of the Neuro-Oncology Program at the Dana-Farber/Harvard Cancer Center, and the Martin A. Samuels Professor of Neurology at Harvard Medical School, Boston, USA. He has spent his career focused on developing novel therapeutics for malignant brain tumours.
Michael Weller is the Chair in the Department of Neurology at University Hospital and University of Zurich, Switzerland. He served as President of the European Association of Neuro-Oncology and chaired the EORTC Brain Tumour Group. His research focuses on innovative therapeutic approaches to brain tumours in vitro, in experimental models in vivo, and in clinical trials.
Oussama Abla, Department of Paediatrics, The Hospital for Sick Children (SickKids), Toronto, Canada
Manmeet S. Ahluwalia, Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, USA
Sanda Alexandrescu, Department of Pathology, Boston Children’s Hospital Harvard Medical School, Boston, USA
Nikolaus Andratschke, Department of Radiation Oncology, Universitätsspital Zürich, Zürich, Switzerland
Terri Armstrong, Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA
Eleonora Aronica, Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands; and Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands
Joachim M. Baehring, Department of Neurology, Yale School of Medicine, New Haven, USA
Osnat Bairey, Hematology Institute, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel; and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Valoraciones
No hay valoraciones aún.